Nordex SE (NRXXY)

Ligand Pharmaceuticals Revenue

Nordex SE had revenue of 1.87B EUR in the quarter ending June 30, 2025, with 0.71% growth. This brings the company's revenue in the last twelve months to 7.17B, up 0.04% year-over-year. In the year 2024, Nordex SE had annual revenue of 7.30B with 12.48% growth.

• Revenue (ttm): 7.17B EUR
• Revenue Growth: +0.04%
• P/S Ratio: 0.70
• Revenue / Employee: 716.88K EUR
• Employees: 10,006
• Market Cap: 5.92B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.30B	809.76M	12.48%
Dec 31, 2023	6.49B	795.51M	13.97%
Dec 31, 2022	5.69B	249.61M	4.59%
Dec 31, 2021	5.44B	793.21M	17.06%
Dec 31, 2020	4.65B	1.37B	41.59%